Elgi Equipments Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 5, 2025, 3:31 pm

Quick Insight

Elgi Equipments Ltd, operating in the compressors industry, currently trades at ₹545 with a market capitalization of ₹17,260 crore. The company's price-to-earnings (P/E) ratio of 49.5 suggests that investors are willing to pay a premium for its earnings, likely due to its robust return on equity (ROE) of 20.1% and return on capital employed (ROCE) of 21.9%. With net profits of ₹350 crore and operating profit margin (OPM) at 15%, Elgi shows solid profitability. However, a relatively high price-to-book value (P/BV) of 11.83x may indicate overvaluation. The company maintains a healthy interest coverage ratio (ICR) of 18.44x, suggesting strong capability to meet interest obligations. With 31.19% promoter holding and substantial institutional interest (FIIs at 29.09%), the stock reflects confidence among key stakeholders. Investors should weigh these factors carefully, as the high valuation metrics may pose risks should earnings growth falter.

Competitors of Elgi Equipments Ltd

All Competitor Stocks of Elgi Equipments Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:20 am

Below is a detailed analysis of the quarterly data for Elgi Equipments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 848.00 Cr. (Dec 2024) to 993.00 Cr., marking an increase of 145.00 Cr..
• For Expenses, as of Mar 2025, the value is 843.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 728.00 Cr. (Dec 2024) to 843.00 Cr., marking an increase of 115.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 119.00 Cr. (Dec 2024) to 150.00 Cr., marking an increase of 31.00 Cr..
• For OPM %, as of Mar 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Dec 2024) to 15.00%, marking an increase of 1.00%.
• For Other Income, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 15.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Mar 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Dec 2024) to 20.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 140.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Dec 2024) to 140.00 Cr., marking an increase of 29.00 Cr..
• For Tax %, as of Mar 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 27.00%.
• For Net Profit, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Dec 2024) to 102.00 Cr., marking an increase of 21.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.22. The value appears strong and on an upward trend. It has increased from 2.54 (Dec 2024) to 3.22, marking an increase of 0.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:54 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 3:18 pm

Below is a detailed analysis of the balance sheet data for Elgi Equipments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 32.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,834.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,580.00 Cr. (Mar 2024) to 1,834.00 Cr., marking an increase of 254.00 Cr..
• For Borrowings, as of Mar 2025, the value is 577.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 638.00 Cr. (Mar 2024) to 577.00 Cr., marking a decrease of 61.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 594.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 558.00 Cr. (Mar 2024) to 594.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,037.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,807.00 Cr. (Mar 2024) to 3,037.00 Cr., marking an increase of 230.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 592.00 Cr.. The value appears strong and on an upward trend. It has increased from 587.00 Cr. (Mar 2024) to 592.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 53.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 53.00 Cr., marking an increase of 43.00 Cr..
• For Investments, as of Mar 2025, the value is 81.00 Cr.. The value appears strong and on an upward trend. It has increased from 41.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 40.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,312.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,170.00 Cr. (Mar 2024) to 2,312.00 Cr., marking an increase of 142.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,807.00 Cr. (Mar 2024) to 3,037.00 Cr., marking an increase of 230.00 Cr..

Notably, the Reserves (1,834.00 Cr.) exceed the Borrowings (577.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Elgi Equipments Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 11.72 (Mar 23) to 9.86, marking a decrease of 1.86.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.86. This value is within the healthy range. It has decreased from 11.71 (Mar 23) to 9.86, marking a decrease of 1.85.
• For Cash EPS (Rs.), as of Mar 24, the value is 12.10. This value is within the healthy range. It has decreased from 14.07 (Mar 23) to 12.10, marking a decrease of 1.97.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 50.84. It has increased from 43.27 (Mar 23) to 50.84, marking an increase of 7.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 50.84. It has increased from 43.27 (Mar 23) to 50.84, marking an increase of 7.57.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 101.54. It has increased from 95.95 (Mar 23) to 101.54, marking an increase of 5.59.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 17.07. This value is within the healthy range. It has increased from 15.78 (Mar 23) to 17.07, marking an increase of 1.29.
• For PBIT / Share (Rs.), as of Mar 24, the value is 14.65. This value is within the healthy range. It has increased from 13.32 (Mar 23) to 14.65, marking an increase of 1.33.
• For PBT / Share (Rs.), as of Mar 24, the value is 13.73. This value is within the healthy range. It has decreased from 16.03 (Mar 23) to 13.73, marking a decrease of 2.30.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 9.68. This value is within the healthy range. It has decreased from 11.62 (Mar 23) to 9.68, marking a decrease of 1.94.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.84. This value is within the healthy range. It has decreased from 11.70 (Mar 23) to 9.84, marking a decrease of 1.86.
• For PBDIT Margin (%), as of Mar 24, the value is 16.81. This value is within the healthy range. It has increased from 16.44 (Mar 23) to 16.81, marking an increase of 0.37.
• For PBIT Margin (%), as of Mar 24, the value is 14.43. This value is within the healthy range. It has increased from 13.88 (Mar 23) to 14.43, marking an increase of 0.55.
• For PBT Margin (%), as of Mar 24, the value is 13.51. This value is within the healthy range. It has decreased from 16.70 (Mar 23) to 13.51, marking a decrease of 3.19.
• For Net Profit Margin (%), as of Mar 24, the value is 9.53. This value is within the healthy range. It has decreased from 12.11 (Mar 23) to 9.53, marking a decrease of 2.58.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.69. This value is within the healthy range. It has decreased from 12.19 (Mar 23) to 9.69, marking a decrease of 2.50.
• For Return on Networth / Equity (%), as of Mar 24, the value is 19.35. This value is within the healthy range. It has decreased from 27.04 (Mar 23) to 19.35, marking a decrease of 7.69.
• For Return on Capital Employeed (%), as of Mar 24, the value is 27.04. This value is within the healthy range. It has decreased from 28.52 (Mar 23) to 27.04, marking a decrease of 1.48.
• For Return On Assets (%), as of Mar 24, the value is 11.05. This value is within the healthy range. It has decreased from 14.82 (Mar 23) to 11.05, marking a decrease of 3.77.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.34. This value is within the healthy range. It has decreased from 0.37 (Mar 23) to 0.34, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.21. It has increased from 0.99 (Mar 23) to 1.21, marking an increase of 0.22.
• For Current Ratio (X), as of Mar 24, the value is 1.92. This value is within the healthy range. It has increased from 1.79 (Mar 23) to 1.92, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 24, the value is 1.36. This value is within the healthy range. It has increased from 1.20 (Mar 23) to 1.36, marking an increase of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.97. This value is below the healthy minimum of 4. It has decreased from 2.52 (Mar 23) to 1.97, marking a decrease of 0.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 20.28. This value is within the healthy range. It has increased from 9.80 (Mar 23) to 20.28, marking an increase of 10.48.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 16.28. This value is below the healthy minimum of 20. It has increased from 8.10 (Mar 23) to 16.28, marking an increase of 8.18.
• For Earning Retention Ratio (%), as of Mar 24, the value is 79.72. This value exceeds the healthy maximum of 70. It has decreased from 90.20 (Mar 23) to 79.72, marking a decrease of 10.48.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 83.72. This value exceeds the healthy maximum of 70. It has decreased from 91.90 (Mar 23) to 83.72, marking a decrease of 8.18.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 18.44. This value is within the healthy range. It has decreased from 25.29 (Mar 23) to 18.44, marking a decrease of 6.85.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 11.45. This value is within the healthy range. It has decreased from 14.30 (Mar 23) to 11.45, marking a decrease of 2.85.
• For Enterprise Value (Cr.), as of Mar 24, the value is 18,846.52. It has increased from 13,869.85 (Mar 23) to 18,846.52, marking an increase of 4,976.67.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.86. This value exceeds the healthy maximum of 3. It has increased from 4.56 (Mar 23) to 5.86, marking an increase of 1.30.
• For EV / EBITDA (X), as of Mar 24, the value is 34.84. This value exceeds the healthy maximum of 15. It has increased from 27.74 (Mar 23) to 34.84, marking an increase of 7.10.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.92. This value exceeds the healthy maximum of 3. It has increased from 4.58 (Mar 23) to 5.92, marking an increase of 1.34.
• For Retention Ratios (%), as of Mar 24, the value is 79.71. This value exceeds the healthy maximum of 70. It has decreased from 90.19 (Mar 23) to 79.71, marking a decrease of 10.48.
• For Price / BV (X), as of Mar 24, the value is 11.83. This value exceeds the healthy maximum of 3. It has increased from 10.16 (Mar 23) to 11.83, marking an increase of 1.67.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.92. This value exceeds the healthy maximum of 3. It has increased from 4.58 (Mar 23) to 5.92, marking an increase of 1.34.
• For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness